granisetron has been researched along with Hepatocellular Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asakura, H; Doya, Y; Hara, H; Hata, K; Hatakeyama, S; Hirose, S; Ichida, T; Isokawa, O; Itoh, S; Nozawa, A; Ohta, H; Takagi, K; Tsuruya, T; Watanabe, T | 1 |
1 trial(s) available for granisetron and Hepatocellular Carcinoma
Article | Year |
---|---|
[Efficacy of granisetron as anti-emetic agent for emesis induced by intra-arterial injection therapy for hepatocellular carcinoma].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Female; Granisetron; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Vomiting | 1998 |